Strata Critical Medical, Inc.
SRTA· Nasdaq
SRTAStrata Critical Medical, Inc.
Filed Mar 12, 2024 · 10-K · 72 days after period end · 0001779128-24-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $47.48M | $38.14M | $24.62M | $7.99M |
| Net Income | -$33.94M | -$27.26M | $772.00K | -$2.36M |
| EPS Diluted | — | — | $0.01 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 12, 2024 · 72 d after period end
